Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 7296092, 12 pages
http://dx.doi.org/10.1155/2016/7296092
Research Article

SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model

1Guangdong Key Laboratory of Shock and Microcirculation Research, Department of Pathophysiology, Southern Medical University, Guangzhou 510515, China
2Department of Anesthesiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian Province, China
3Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
4Department of Critical Care Medicine, Institute of Translational Medicine, The First People’s Hospital of Chenzhou, Hunan, Chenzhou, China

Received 19 April 2016; Revised 7 September 2016; Accepted 30 October 2016

Academic Editor: Victor M. Victor

Copyright © 2016 Siqi Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Singer, C. S. Deutschman, C. W. Seymour et al., “The third international consensus definitions for sepsis and septic shock (Sepsis-3),” The Journal of the American Medical Association, vol. 315, no. 8, pp. 801–810, 2016. View at Publisher · View at Google Scholar
  2. C. M. Torio and R. M. Andrews, National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011, Statistical Brief #160, 2006.
  3. J.-L. Vincent, J. C. Marshall, S. A. Ñamendys-Silva et al., “Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit,” The Lancet Respiratory Medicine, vol. 2, no. 5, pp. 380–386, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Fleischmann, A. Scherag, N. K. Adhikari et al., “Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations,” American Journal of Respiratory and Critical Care Medicine, vol. 193, no. 3, pp. 259–272, 2016. View at Google Scholar
  5. X. Dai, Z. Zeng, C. Fu, S. Zhang, Y. Cai, and Z. Chen, “Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury,” Critical Care, vol. 19, article 223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tran, D. Tam, A. Bardia et al., “PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice,” The Journal of Clinical Investigation, vol. 121, no. 10, pp. 4003–4014, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Gao, Z. Zeng, T. Li et al., “Polydatin inhibits mitochondrial dysfunction in the renal tubular epithelial cells of a rat model of sepsis-induced acute kidney injury,” Anesthesia and Analgesia, vol. 121, no. 5, pp. 1251–1260, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Nogueiras, K. M. Habegger, N. Chaudhary et al., “Sirtuin 1 and sirtuin 3: physiological modulators of metabolism,” Physiological Reviews, vol. 92, no. 3, pp. 1479–1514, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. V. T. Vachharajani, T. Liu, X. Wang, J. J. Hoth, B. K. Yoza, and C. E. McCall, “Sirtuins link inflammation and metabolism,” Journal of Immunology Research, vol. 2016, Article ID 8167273, 10 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Gao, Z. Ma, Y. Hu, J. Chen, S. Shetty, and J. Fu, “Sirt1 restrains lung inflammasome activation in a murine model of sepsis,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 308, no. 8, pp. L847–L853, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Opal, J. L. Ellis, V. Suri et al., “Harmacological Sirt1 activation improves mortality and markedly alters transcriptional profiles that accompany experimental sepsis,” Shock, vol. 45, no. 4, pp. 411–418, 2016. View at Publisher · View at Google Scholar
  12. H. Pi, S. Xu, R. J. Reiter et al., “SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin,” Autophagy, vol. 11, no. 7, pp. 1037–1051, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Qiu, K. Brown, M. D. Hirschey, E. Verdin, and D. Chen, “Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation,” Cell Metabolism, vol. 12, no. 6, pp. 662–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Li, X. Meng, H. Bian, N. Burns, K.-S. Zhao, and R. Song, “Activation of sirtuin 1/3 improves vascular hyporeactivity in severe hemorrhagic shock by alleviation of mitochondrial damage,” Oncotarget, vol. 6, no. 35, pp. 36998–37011, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Zeng, Y. Yang, X. Dai et al., “Polydatin ameliorates injury to the small intestine induced by hemorrhagic shock via SIRT3 activation-mediated mitochondrial protection,” Expert Opinion on Therapeutic Targets, vol. 20, no. 6, pp. 645–652, 2016. View at Publisher · View at Google Scholar
  16. D. H. Shin, Y.-J. Choi, and J.-W. Park, “SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin,” Cancer Research, vol. 74, no. 1, pp. 298–308, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zeng, Z. Chen, S. Xu et al., “Polydatin protecting kidneys against hemorrhagic shock-induced mitochondrial dysfunction via SIRT1 activation and p53 deacetylation,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 1737185, 15 pages, 2016. View at Publisher · View at Google Scholar
  18. Z. Zeng, Z. Chen, S. Xu, R. Song, H. Yang, and K.-S. Zhao, “Polydatin alleviates small intestine injury during Hemorrhagic shock as a SIRT1 activator,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 965961, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. R. H. Houtkooper, E. Pirinen, and J. Auwerx, “Sirtuins as regulators of metabolism and healthspan,” Nature Reviews Molecular Cell Biology, vol. 13, no. 4, pp. 225–238, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M.-K. Han, E.-K. Song, Y. Guo, X. Ou, C. Mantel, and H. E. Broxmeyer, “SIRT1 regulates apoptosis and nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization,” Cell Stem Cell, vol. 2, no. 3, pp. 241–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Jian, S. Yang, I. H. Chaudry, and R. Raju, “Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1,” Molecular Medicine, vol. 18, no. 2, pp. 209–214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Li, X. Wang, M. Zhao, R. Song, and K.-S. Zhao, “Polydatin protects hepatocytes against mitochondrial injury in acute severe hemorrhagic shock via SIRT1-SOD2 pathway,” Expert Opinion on Therapeutic Targets, vol. 19, no. 7, pp. 997–1010, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Wang, R. Song, H. N. Bian, U. T. Brunk, M. Zhao, and K.-S. Zhao, “Polydatin, a natural polyphenol, protects arterial smooth muscle cells against mitochondrial dysfunction and lysosomal destabilization following hemorrhagic shock,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 302, no. 7, pp. R805–R814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Opal, J. L. Ellis, V. Suri et al., “Pharmacological SIRT1 activation improves mortality and markedly alters transcriptional profiles that accompany experimental sepsis,” Shock, vol. 45, no. 4, pp. 411–418, 2016. View at Publisher · View at Google Scholar
  25. T. Li, J. Zhang, J. Feng et al., “Resveratrol reduces acute lung injury in a LPS-induced sepsis mouse model via activation of Sirt1,” Molecular Medicine Reports, vol. 7, no. 6, pp. 1889–1895, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. S. Hwang, H. S. Choi, S. A. Ham et al., “Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia,” Scientific Reports, vol. 5, Article ID 15971, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. T. D. Walko III, V. Di Caro, J. Piganelli, T. R. Billiar, R. S. Clark, and R. K. Aneja, “Poly(ADP-ribose) polymerase 1-sirtuin 1 functional interplay regulates LPS-mediated high mobility group box 1 secretion,” Molecular Medicine, vol. 20, pp. 612–624, 2014. View at Publisher · View at Google Scholar
  28. V. T. Vachharajani, T. Liu, C. M. Brown et al., “SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome,” Journal of Leukocyte Biology, vol. 96, no. 5, pp. 785–796, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. T. F. Liu, V. Vachharajani, P. Millet, M. S. Bharadwaj, A. J. Molina, and C. E. McCall, “Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis,” The Journal of Biological Chemistry, vol. 290, no. 1, pp. 396–408, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. P. R. Mayeux and L. A. MacMillan-Crow, “Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury,” Pharmacology and Therapeutics, vol. 134, no. 2, pp. 139–155, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Nakano, K. Doi, H. Kitamura et al., “Reduction of tubular flow rate as a mechanism of oliguria in the early phase of endotoxemia revealed by intravital imaging,” Journal of the American Society of Nephrology, vol. 26, no. 12, pp. 3035–3044, 2015. View at Publisher · View at Google Scholar · View at Scopus